Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

329
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

JCO precision oncology·2026
Same author

Colorectal cancer screening: An update to the American Cancer Society guideline, 2026.

CA: a cancer journal for clinicians·2026
Same author

Impact of Multicancer Screening on Late-Stage Cancer at Diagnosis in Breast Cancer Survivors: A Modeling Study.

JCO precision oncology·2026
Same author

Adjusting for non-compliance and contamination with a more plausible assumption.

Journal of medical screening·2026
Same author

The efficient stored specimen design for evaluating multiple screening technologies: Application to multicancer detection tests.

Journal of medical screening·2025
Same author

Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline.

CA: a cancer journal for clinicians·2025

Related Experiment Video

Updated: Jul 2, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K

Prediagnostic evaluation of multicancer detection tests: design and analysis considerations.

Stuart G Baker1, Ruth Etzioni2

  • 1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.

Journal of the National Cancer Institute
|February 29, 2024
PubMed
Summary

A new sample size method can significantly reduce the number of participants needed for multicancer early detection tests, improving the accuracy of positive predictive values in prediagnostic studies.

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.6K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K

Related Experiment Videos

Last Updated: Jul 2, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.6K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K

Area of Science:

  • Biostatistics
  • Oncology
  • Molecular Diagnostics

Background:

  • Multicancer detection tests aim to identify preclinical cancers via blood-based molecular signals.
  • Prediagnostic performance studies are crucial for evaluating these tests using stored specimens.

Purpose of the Study:

  • To evaluate the effectiveness of the sample size trade-off method for prediagnostic studies of multicancer detection tests.
  • To demonstrate sample size reduction and improved positive predictive value estimation.

Main Methods:

  • The study compares the sample size trade-off method with standard calculations for prediagnostic performance studies.
  • Key metrics include cancer-specific true-positive and false-positive rates, and positive predictive value.
  • The sample size trade-off method prioritizes a zero-false-positive rate over precise true-positive rate targeting.

Main Results:

  • The sample size trade-off method substantially reduces required sample sizes.
  • For ovarian cancer (rarest case), it yields a sample size of 163,000 versus 720,000 with standard methods.
  • This method increases the lower bound of the positive predictive value.

Conclusions:

  • The sample size trade-off method offers a more efficient approach for prediagnostic evaluation of multicancer detection tests.
  • Recommendations are provided for specimen repository planning and test evaluation.
  • This method enhances the reliability of predictive performance metrics.